BBA
Baker Bros. Advisors’s Roivant Sciences ROIV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.5M | Hold |
3,767,773
| – | – | 0.41% | 28 |
|
|
2025
Q1 | $38M | Hold |
3,767,773
| – | – | 0.42% | 27 |
|
|
2024
Q4 | $44.6M | Buy |
3,767,773
+969,057
| +35% | +$11.5M | 0.48% | 27 |
|
|
2024
Q3 | $32.3M | Hold |
2,798,716
| – | – | 0.33% | 33 |
|
|
2024
Q2 | $29.6M | Sell |
2,798,716
-4,615,118
| -62% | -$48.8M | 0.38% | 34 |
|
|
2024
Q1 | $78.1M | Sell |
7,413,834
-179,190
| -2% | -$1.89M | 0.98% | 13 |
|
|
2023
Q4 | $85.3M | Sell |
7,593,024
-4,284,147
| -36% | -$48.1M | 0.97% | 12 |
|
|
2023
Q3 | $139M | Buy |
11,877,171
+2,448,579
| +26% | +$28.6M | 0.8% | 8 |
|
|
2023
Q2 | $95M | Buy |
9,428,592
+4,651,162
| +97% | +$46.9M | 0.55% | 16 |
|
|
2023
Q1 | $35.3M | Buy |
4,777,430
+4,060,777
| +567% | +$30M | 0.19% | 27 |
|
|
2022
Q4 | $5.73M | Buy |
+716,653
| New | +$5.73M | 0.03% | 76 |
|